SCHEMBL3564879

SCHEMBL3564879

COc1c(O)ccc(N[C]=O)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 2/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
RECQL P46063 2/20 0.37
NPC1 O15118 1/20 0.37
AMY1A P0DUB6 1/20 0.37
THRB P10828 1/20 0.37
APEX1 P27695 1/20 0.37
BLM P54132 1/20 0.37
CASP6 P55212 1/20 0.37
GFER P55789 1/20 0.37
CA1 P00915 3/20 0.37
CA12 O43570 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA13 Q8N1Q1 1/20 0.37
CA2 P00918 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556415 0.87 CA1 (0.38) MEN1KMT2AKDM4EPOLBGAA
SCHEMBL3570348 0.84 MAPT (0.49) KDM4EGAAMAPTNPC1CA1
SCHEMBL3572869 0.77 MAPT (0.41) MEN1KMT2AKDM4EMAPTRECQL
SCHEMBL5610326 0.77 SELL (0.37) RECQLCA1CA2ALDH1A1
SCHEMBL3563058 0.76 MAPT (0.40) MEN1KMT2AKDM4EMAPTRECQL
SCHEMBL3564882 0.75 CA1 (0.43) CA1CA12CA7CA9CA13
SCHEMBL11882012 0.71 MAPT (0.48) KDM4EGAAMAPTCA1CA12
SCHEMBL3513510 0.70 MAPT (0.37) KMT2AKDM4EPOLBMAPTNPC1
SCHEMBL69925 0.68 TDP1 (0.52) MEN1KMT2AKDM4EGAAMAPT
SCHEMBL29403778 0.68 TDP1 (0.52) MEN1KMT2AKDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662826-B2 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same SHIONOGI & CO., LTD. (JP) 2010-02-16 US disclosed
US-20060089362-A1 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same SHIONOGI & CO., LTD (JP) 2006-04-27 US disclosed
EP-1505068-A1 PYRAZOLO (1,5-a) PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 2005-02-09 EP disclosed
EP-1155698-A1 ORGANOBORON COMPOUNDS EXHIBITING ANTICOCCIDIAL ACTIVITIES Nitto Kasei Co., Ltd. (JP) 2001-11-21 EP disclosed
EP-1057825-A1 ISOFLAVANE DERIVATIVES AND IMMUNOPOTENTIATING COMPOSITIONS CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 2000-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089362-A1 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same NADK, PNPO, NQO1 MEN1 3501/4885KMT2A 2263/4885KDM4E 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.